To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

Summary

This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 October 2017

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 19 October 2017

   Introduced

   Introduced in House

   Source: IntroReferral

3. 19 October 2017

   Introduced

   Introduced in House

   Source: IntroReferral

4. 20 October 2017

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 1 November 2017

   Referred

   Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 19 October 2017 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 19 October 2017

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 19 October 2017

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 19 October 2017

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Kuster, Ann M. [D-NH-2] · D · Sponsor
• Rep. Jenkins, Evan H. [R-WV-3] · R · Sponsor
• Rep. Ryan, Tim [D-OH-13] · D · Sponsor
• Rep. Cooper, Jim [D-TN-5] · D · Sponsor
• Rep. Esty, Elizabeth H. [D-CT-5] · D · Cosponsor
• Rep. Doggett, Lloyd [D-TX-37] · D · Cosponsor
• Rep. Cohen, Steve [D-TN-9] · D · Cosponsor
• Rep. DelBene, Suzan K. [D-WA-1] · D · Cosponsor
• Rep. Jackson Lee, Sheila [D-TX-18] · D · Cosponsor
• · hsju00 · Standing
• · hsif00 · Standing

Related records

• related to → A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.